148 related articles for article (PubMed ID: 9422320)
1. Sclerosing stromal tumor of the ovary: a clinicopathologic, immunohistochemical, ultrastructural, and cytogenetic analysis with special reference to its vasculature.
Kawauchi S; Tsuji T; Kaku T; Kamura T; Nakano H; Tsuneyoshi M
Am J Surg Pathol; 1998 Jan; 22(1):83-92. PubMed ID: 9422320
[TBL] [Abstract][Full Text] [Related]
2. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.
Boocock CA; Charnock-Jones DS; Sharkey AM; McLaren J; Barker PJ; Wright KA; Twentyman PR; Smith SK
J Natl Cancer Inst; 1995 Apr; 87(7):506-16. PubMed ID: 7707437
[TBL] [Abstract][Full Text] [Related]
3. A case of a sclerosing stromal ovarian tumor that expresses VEGF.
Ishioka S; Sagae S; Saito T; Kiya T; Akutagawa N; Sugimura M; Kudo R
J Obstet Gynaecol Res; 2000 Feb; 26(1):35-8. PubMed ID: 10761329
[TBL] [Abstract][Full Text] [Related]
4. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
[TBL] [Abstract][Full Text] [Related]
5. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
[TBL] [Abstract][Full Text] [Related]
6. The vascular endothelial growth factor/fms-like tyrosine kinase system in human ovary during the menstrual cycle and early pregnancy.
Otani N; Minami S; Yamoto M; Shikone T; Otani H; Nishiyama R; Otani T; Nakano R
J Clin Endocrinol Metab; 1999 Oct; 84(10):3845-51. PubMed ID: 10523040
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor and its receptors in normal human testicular tissue.
Ergün S; Kiliç N; Fiedler W; Mukhopadhyay AK
Mol Cell Endocrinol; 1997 Jul; 131(1):9-20. PubMed ID: 9256359
[TBL] [Abstract][Full Text] [Related]
8. RT in situ PCR for VEGF mRNA in sclerosing stromal tumor.
Kawauchi S; Fukuda T; Tsuneyoshi M
Am J Surg Pathol; 2000 Jan; 24(1):156-7. PubMed ID: 10632502
[No Abstract] [Full Text] [Related]
9. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
[TBL] [Abstract][Full Text] [Related]
10. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
Brown LF; Tognazzi K; Dvorak HF; Harrist TJ
Am J Pathol; 1996 Apr; 148(4):1065-74. PubMed ID: 8644848
[TBL] [Abstract][Full Text] [Related]
11. Expression of angiogenic factors in sclerosing stromal tumours of the ovary.
Hirakawa T; Kawano Y; Mizoguchi C; Nasu K; Narahara H
J Obstet Gynaecol; 2018 Jul; 38(5):682-685. PubMed ID: 29433373
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological Characteristics of Ovarian Sclerosing Stromal Tumor with an Emphasis on TFE3 Overexpression.
Park CK; Kim HS
Anticancer Res; 2017 Oct; 37(10):5441-5447. PubMed ID: 28982854
[TBL] [Abstract][Full Text] [Related]
13. [Sclerosing stromal tumor--a rare benign ovarian neoplasm].
Tomsová M; Krepinská E; Spacek J
Ceska Gynekol; 2008 Jun; 73(3):188-91. PubMed ID: 18646673
[TBL] [Abstract][Full Text] [Related]
14. Sclerosing stromal tumors of the ovary: a clinicopathologic, immunohistochemical and cytogenetic analysis of three cases.
Kostopoulou E; Moulla A; Giakoustidis D; Leontsini M
Eur J Gynaecol Oncol; 2004; 25(2):257-60. PubMed ID: 15032299
[TBL] [Abstract][Full Text] [Related]
15. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptor flt-1 in microcystic meningiomas.
Christov C; Lechapt-Zalcman E; Adle-Biassette H; Nachev S; Gherardi RK
Acta Neuropathol; 1999 Oct; 98(4):414-20. PubMed ID: 10502048
[TBL] [Abstract][Full Text] [Related]
16. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer.
Brown LF; Berse B; Jackman RW; Tognazzi K; Guidi AJ; Dvorak HF; Senger DR; Connolly JL; Schnitt SJ
Hum Pathol; 1995 Jan; 26(1):86-91. PubMed ID: 7821921
[TBL] [Abstract][Full Text] [Related]
17. Expression and tissue concentration of vascular endothelial growth factor, its receptors, and localization in the bovine corpus luteum during estrous cycle and pregnancy.
Berisha B; Schams D; Kosmann M; Amselgruber W; Einspanier R
Biol Reprod; 2000 Oct; 63(4):1106-14. PubMed ID: 10993833
[TBL] [Abstract][Full Text] [Related]
18. Cyclic changes in expression of mRNA of vascular endothelial growth factor, its receptors Flt-1 and KDR/Flk-1, and Ets-1 in human corpora lutea.
Endo T; Kitajima Y; Nishikawa A; Manase K; Shibuya M; Kudo R
Fertil Steril; 2001 Oct; 76(4):762-8. PubMed ID: 11591411
[TBL] [Abstract][Full Text] [Related]
19. [Expression of vascular endothelial growth factor and its receptor (Flt-1) in breast carcinoma].
Wu H; Li Y; Zhu G; Zhang L; Zhang X; He X
Zhonghua Yi Xue Za Zhi; 2002 May; 82(10):708-11. PubMed ID: 12133473
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of vascular endothelial growth factor and its receptor fms-like-tyrosine kinase is mediated by nitric oxide in rat renal mesangial cells.
Frank S; Stallmeyer B; Kämpfer H; Schaffner C; Pfeilschifter J
Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):367-74. PubMed ID: 10024512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
